PARTNER WITH US FOR
TOPICALS, SOFTGELS & ORAL
FORMULATION DESIGNING

We believe that identifying the right product and right opportunity is key to success. We are focused on developing challenging and complex formulations with focus on quality, robustness and commercial viability. Combining the crucial elements of technology, time and cost in an efficient mixture, we make sure the product delivery with desired quality attributes. We follow QbD principles regularly throughout the product development.

Neovertex is established to focus on the business strategies
  • Cost leadership
  • Differentiation
  • Quality
We are partnered with global pharmaceutical companies for the development and technology transfer of following formulation systems
  • 505 (b)2 Topical formulations
  • Generic Topical formulations
  • Soft gelatin capsules
  • Complex oral controlled release formulations
  • Liquid Oral dosage forms
Apart from generic product development for USA, Europe we are concentrated on Centre of excellence projects like 505(b)2 projects, solubility and bioavailability enhancement, proof of Concept (POC) development studies.

about NEOVERTEX
laboratories

NEOVERTEX laboratories was founded with an intention to support the global pharmaceutical industry in end to end product development of complex and niche products. NEOVERTEX is established by a group of dynamic experienced professionals who carries with them a rich experience of developing quality products to global regulated markets. The professional management of NEOVERTEX are expertised in diverse technical areas like formulation research, analytical development, preclinical / clinical and global regulatory affairs. We firmly believe that the technical capabilities and multifaceted international exposure of the founding team will ensure in offering timely project completion and delivery as per customer standards.


Do you want to…

Take some time and meet our team?

...or maybe see some Facts about us?

FORMULATION DESIGN

Our product development is purely based on scientific approaches and quality risk management tools. Quality by design principles are being applied to ensure a robust formulation design delivering consistent product performance.



TOPICAL FORMULATIONS

NEOVERTEX is equipped with a team having extensive technical capabilities and expertise in developing topical formulations complying to global regulatory standards.


SOFTGELS

Our team has technical expertise in developing soft gelatin and liquid filled hard gelatin capsule through QbD approach for US market.


ORAL SOLID FORMULATIONS

NEOVERTEX laboratories are equipped with an efficient team and state of art infrastructure to develop all conventional and controlled release formulations.

CENTER OF EXCELLENCE

EARLY BIRD PROJECTS

Early Bird projects are designed to have a clear advantage in the much competitive and time bound projects.

505(b)2 PROJECTS

505(b)(2) is one of the alternative regulatory pathways, which is designed to allow the approval of a drug which is not new, but differs in several meaningful aspects.

WANT TO KNOW MORE ABOUT OUR COMPANY? CURIOUS WHAT ELSE WE DO?